Swiss Life Asset Management Ltd Grows Stake in MetLife, Inc. $MET

Swiss Life Asset Management Ltd lifted its holdings in shares of MetLife, Inc. (NYSE:MET) by 9.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 80,541 shares of the financial services provider’s stock after acquiring an additional 6,698 shares during the period. Swiss Life Asset Management Ltd’s holdings in MetLife were worth $6,358,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MET. Vanguard Group Inc. raised its holdings in MetLife by 12.1% during the fourth quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock worth $5,727,518,000 after purchasing an additional 7,805,814 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of MetLife by 105.3% in the 3rd quarter. AQR Capital Management LLC now owns 3,305,620 shares of the financial services provider’s stock valued at $271,424,000 after buying an additional 1,695,563 shares in the last quarter. First Trust Advisors LP grew its position in shares of MetLife by 173.4% in the 3rd quarter. First Trust Advisors LP now owns 1,641,253 shares of the financial services provider’s stock valued at $135,190,000 after buying an additional 1,040,894 shares during the last quarter. Man Group plc grew its position in shares of MetLife by 325.5% in the 2nd quarter. Man Group plc now owns 1,344,551 shares of the financial services provider’s stock valued at $108,129,000 after buying an additional 1,028,554 shares during the last quarter. Finally, PFA Pension Forsikringsaktieselskab acquired a new stake in MetLife during the 4th quarter worth $81,494,000. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Trading Down 0.7%

NYSE MET opened at $78.05 on Thursday. The firm’s fifty day moving average is $73.65 and its two-hundred day moving average is $76.52. MetLife, Inc. has a one year low of $67.33 and a one year high of $83.85. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.20 and a current ratio of 0.20. The firm has a market cap of $50.22 billion, a PE ratio of 15.13, a P/E/G ratio of 0.69 and a beta of 0.78.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.15. The business had revenue of $14.18 billion during the quarter, compared to the consensus estimate of $19.49 billion. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.96 earnings per share. Analysts expect that MetLife, Inc. will post 9.9 earnings per share for the current year.

MetLife Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 12th will be paid a $0.5925 dividend. This is an increase from MetLife’s previous quarterly dividend of $0.57. The ex-dividend date is Tuesday, May 12th. This represents a $2.37 annualized dividend and a dividend yield of 3.0%. MetLife’s dividend payout ratio (DPR) is 45.93%.

MetLife News Summary

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Keefe, Bruyette & Woods lifted its price target on MetLife to $98 from $87 and kept an outperform rating, implying meaningful upside from current levels.
• Positive Sentiment: JPMorgan raised its price target on MetLife to $96 from $95 and maintained an overweight rating, reinforcing a bullish outlook for the insurer.
• Positive Sentiment: MetLife announced or was linked to several healthcare partnership updates, including direct billing for obesity care in the UAE and a virtual care partnership with Mediclinic Middle East, which may help strengthen its employee benefits and health-focused offerings. Lilly and MetLife introduce direct billing model for obesity care for Lilly employees in the UAE Mediclinic Middle East and MetLife partner to deliver nationwide access to virtual care
• Neutral Sentiment: Recent articles about MetLife Stadium and World Cup ticket, seating, and transportation issues are centered on the venue name, not MetLife, Inc.’s insurance operations, so they are unlikely to have a direct impact on the stock. See which MetLife World Cup resale ticket prices are rising and falling MetLife Seating Chart: How to find the best seats for the World Cup World Cup train, bus tickets from NYC to MetLife Stadium get another price cut MetLife Stadium travel workaround found which cuts round-trip price to $20 for World Cup The NY Giants are opening 2026 at MetLife against the Cowboys. Get tickets now

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Wells Fargo & Company upped their price objective on shares of MetLife from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Tuesday. Morgan Stanley reduced their target price on MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. TD Cowen decreased their target price on MetLife from $91.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, March 11th. Weiss Ratings upgraded MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, May 1st. Finally, Wall Street Zen cut MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, MetLife presently has an average rating of “Moderate Buy” and an average target price of $95.15.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.